Friday, December 17, 2021

In a trial, Pfizer-BioNTech’s low-dose shot did not provoke an adequate immune response in 2- to 5-year-olds.

Calling the vaccine a “three-dose series,” the company now plans to test three doses of its vaccine in children ages six months to 17 years.

from NYT > Top Stories https://ift.tt/33FLKXN
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Mark Sanchez, Ex-NFL Quarterback, Is Injured in Stabbing

Fox Sports, the network where Mr. Sanchez works as a commentator, said he was in stable condition. from NYT > Top Stories https://ift.t...